DNALI1 Promotes Neurodegeneration after Traumatic Brain Injury via Inhibition of Autophagosome-Lysosome Fusion.
Xulong DingShuqiang CaoQing WangBin DuKefeng LuShiqian QiYing ChengQing-Zhang TuoWeibo LiangPeng LeiPublished in: Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2024)
Traumatic brain injury (TBI) leads to progressive neurodegeneration that may be caused by chronic traumatic encephalopathy (CTE). However, the precise mechanism remains unclear. Herein, the study identifies a crucial protein, axonemal dynein light intermediate polypeptide 1 (DNALI1), and elucidated its potential pathogenic role in post-TBI neurodegeneration. The DNALI1 gene is systematically screened through analyses of Aging, Dementia, and TBI studies, confirming its elevated expression both in vitro and in vivo. Moreover, it is observed that altered DNALI1 expression under normal conditions has no discernible effect. However, upon overexpression, DNALI1 inhibits autophagosome-lysosome fusion, reduces autophagic flux, and exacerbates cell death under pathological conditions. DNALI1 silencing significantly enhances autophagic flux and alleviates neurodegeneration in a CTE model. These findings highlight DNALI1 as a potential key target for preventing TBI-related neurodegeneration.
Keyphrases
- traumatic brain injury
- cell death
- severe traumatic brain injury
- poor prognosis
- mild traumatic brain injury
- genome wide
- spinal cord injury
- multiple sclerosis
- fluorescent probe
- mild cognitive impairment
- gene expression
- copy number
- signaling pathway
- dna methylation
- risk assessment
- mouse model
- transcription factor
- small molecule
- human health
- single molecule
- case control